Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -162.17%-4.26M | 265.83%1.45M | -147.85%-3.17M | 1,176.32%15.73M | 189.51%3.13M | 226.06%6.84M | -125.31%-872K | 64.75%6.62M | 86.37%-1.46M | -184.77%-3.5M |
| Net income from continuing operations | -342.50%-30.77M | -4.20%-11.71M | 22.75%-13.36M | -71.42%-66.82M | -215.38%-31.34M | 28.92%-6.95M | -47.48%-11.24M | -48.51%-17.29M | -72.45%-38.98M | 9.87%-9.94M |
| Operating gains losses | 895.25%7.2M | 20.32%1.28M | -209.06%-2.4M | 47.94%-1.11M | -602.32%-3.47M | 55.75%-905K | 180.23%1.06M | 302.38%2.2M | 15.72%-2.13M | -81.06%690K |
| Depreciation and amortization | 1.14%7.3M | 28.66%11.79M | 25.34%9.28M | -20.93%33.29M | -11.20%9.51M | -37.95%7.21M | 6.53%9.17M | -33.70%7.4M | 139.17%42.11M | 207.88%10.71M |
| Asset impairment expenditure | ---- | ---- | ---- | --27.2M | ---- | ---- | ---- | ---- | --0 | ---- |
| Remuneration paid in stock | 36.47%232K | -93.84%13K | 186.67%52K | -48.11%493K | -27.43%172K | -20.19%170K | -14.57%211K | -123.72%-60K | -4.43%950K | -61.53%237K |
| Deferred tax | --0 | --0 | --0 | -69.67%-884K | -265.67%-490K | 48.76%-103K | -568.42%-508K | 297.27%217K | -148.10%-521K | ---134K |
| Other non cashItems | 66.63%13.62M | -191.46%-1.01M | -23.79%9.92M | 465.21%18.77M | 69.03%-3.53M | 494.64%8.17M | -75.12%1.1M | 234.39%13.02M | -203.28%-5.14M | -1,270.30%-11.39M |
| Change In working capital | -143.81%-1.83M | 261.29%1.08M | -688.62%-6.68M | 101.73%4.56M | -23.45%4.84M | 76.29%-751K | 17.51%-669K | 1,403.45%1.13M | 125.23%2.26M | 387.96%6.32M |
| -Change in receivables | -1,066.60%-4.6M | 896.74%4.16M | -436.03%-2.45M | 67.90%-494K | 51.10%-1.18M | 149.17%476K | -151.03%-522K | -10.43%730K | 77.76%-1.54M | 73.59%-2.41M |
| -Change in inventory | 480.95%1.1M | -132.00%-160K | -113.46%-169K | -67.23%3.42M | -2.00%1.47M | -90.25%189K | -74.72%500K | -74.91%1.26M | 208.88%10.42M | 184.55%1.5M |
| -Change in payables and accrued expense | 159.89%2.39M | -144.36%-4.7M | -632.63%-2.27M | 124.66%1.63M | 131.86%2.21M | -54.39%920K | 11.53%-1.93M | -11.06%426K | -127.58%-6.63M | -143.23%-6.95M |
| -Change in other working capital | ---- | ---- | -39.59%-1.78M | ---- | ---- | 75.10%-1.53M | 12.35%-1.43M | 79.99%-1.28M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -162.17%-4.26M | 266.17%1.45M | -147.89%-3.17M | 1,160.23%15.49M | 182.79%2.9M | 226.06%6.84M | -125.31%-872K | 64.75%6.62M | 86.37%-1.46M | -184.77%-3.5M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 60.00%-1.1M | -375.45%-4.46M | -30.84%-5.89M | 35.22%-10.62M | 41.56%-2.43M | 68.86%-2.76M | -523.98%-937K | -24.79%-4.5M | 1.25%-16.4M | 12.48%-4.15M |
| Net PPE purchase and sale | 49.43%-1.41M | -58.66%-4.7M | -40.17%-5.86M | 22.22%-12.56M | 37.09%-2.62M | 68.66%-2.79M | -700.27%-2.96M | -54.87%-4.18M | -15.52%-16.14M | -15.00%-4.17M |
| Net intangibles purchas and sale | ---- | ---- | ---- | --424K | ---- | ---- | ---- | ---- | --0 | ---- |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net investment purchase and sale | --0 | ---- | ---- | ---20K | --0 | --0 | ---- | ---- | --0 | --0 |
| Interest received (cash flow from investment activities) | -56.67%13K | 0.00%31K | -40.00%24K | 43.33%129K | 55.56%28K | -23.08%30K | 410.00%31K | -6.98%40K | -51.61%90K | -50.00%18K |
| Net other investing changes | --294K | -89.47%212K | 85.28%-53K | 500.57%1.4M | ---255K | --0 | --2.01M | -3.15%-360K | -2.95%-349K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 60.00%-1.1M | -375.45%-4.46M | -30.84%-5.89M | 35.22%-10.62M | 41.56%-2.43M | 68.86%-2.76M | -523.98%-937K | -24.79%-4.5M | 1.25%-16.4M | 12.48%-4.15M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,623.21%2.9M | 196.21%1.09M | 2,663.61%9.04M | -111.36%-2.08M | -114.53%-1.44M | -98.47%168K | 9.92%-1.14M | 125.00%327K | 173.20%18.34M | 6,198.16%9.94M |
| Net issuance payments of debt | 62.55%2.9M | 1,230.93%1.1M | -109.72%-100K | -68.81%2.62M | -101.91%-93K | -53.87%1.78M | -119.17%-97K | 223.23%1.03M | 111.08%8.4M | 3,085.89%4.87M |
| Net common stock issuance | --402K | ---3K | --9.59M | --0 | --0 | --0 | --0 | --0 | 360.31%12.59M | --6.39M |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Interest paid (cash flow from financing activities) | --0 | 99.81%-2K | 35.90%-450K | -93.89%-4.6M | -10.23%-1.25M | -302.24%-1.61M | -183.61%-1.04M | -48.41%-702K | ---2.37M | ---1.13M |
| Net other financing activities | ---- | ---- | ---- | 62.59%-101K | ---- | ---- | ---- | ---- | ---270K | ---186K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,623.21%2.9M | 196.21%1.09M | 2,663.61%9.04M | -111.36%-2.08M | -114.53%-1.44M | -98.47%168K | 9.92%-1.14M | 125.00%327K | 173.20%18.34M | 6,198.16%9.94M |
| Net cash flow | ||||||||||
| Beginning cash position | 39.55%4.74M | 4.90%6.66M | 71.10%6.68M | 12.03%3.9M | 356.96%7.65M | -32.01%3.4M | 144.51%6.35M | 12.03%3.9M | -85.59%3.48M | -82.57%1.68M |
| Current changes in cash | -157.95%-2.46M | 34.99%-1.91M | -100.94%-23K | 480.79%2.78M | -142.62%-976K | 227.96%4.25M | -222.36%-2.94M | 374.05%2.45M | 102.32%479K | 137.32%2.29M |
| Effect of exchange rate changes | --0 | --0 | 112.50%1K | 88.33%-7K | --0 | --4K | 0.00%-3K | -260.00%-8K | 24.05%-60K | -720.00%-62K |
| End cash Position | -70.24%2.28M | 39.55%4.74M | 4.90%6.66M | 71.10%6.68M | 71.10%6.68M | 356.96%7.65M | -32.01%3.4M | 144.51%6.35M | 12.03%3.9M | 12.03%3.9M |
| Free cash from | -239.99%-5.68M | 15.16%-3.25M | -474.01%-9.14M | 116.51%2.91M | 103.16%242K | 128.29%4.05M | -224.65%-3.83M | 84.94%2.44M | 28.71%-17.6M | -57.94%-7.67M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.